Files
2026-07-06 17:28:36 -04:00

6.4 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Controlled substances; use of FDA-approved substance upon publication of final rule, etc. Authorizes the Board of Pharmacy (Board) to designate, deschedule, or reschedule as a controlled substance any substance 30 days after publication in the Federal Register of a final or interim final order or rule designating such substance as a controlled substance or descheduling or rescheduling such substance. Under current law, the Board may act 120 days from such publication date. The bill also provides that a person is immune from prosecution for prescribing, administering, dispensing, or possessing pursuant to a valid prescription a substance approved as a prescription drug by the U.S. Food and Drug Administration on or after July 1, 2017, in accordance with a final or interim final order or rule despite the fact that such substance has not been scheduled by the Board. The immunity provided by the bill remains in effect until the earlier of (i) nine months from the date of the publication of the interim final order or rule or, if published within nine months of the interim final order or rule, the final order or rule or (ii) the substance is scheduled by the Board or by law. This bill is identical to us/states/va Virginia General Assembly 2017 SB 1403 Virginia SB 1403 (2017)
bill
Commissions
Boards and Institutions Generally
Narcotics and Drugs
enacted
Siobhan S. Dunnavant
5 23 6 2017-01-11 2017-03-13 openstates ocd-bill/f8b20672-d6b8-472e-ab4b-f3a77bcedecb http://lis.virginia.gov/cgi-bin/legp604.exe?171+sum+SB1403 7c4d1837625214015a7c356b339162d3f40da419bdc52b2fce99f6c3239c582e 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-va

Virginia SB 1403 (2017) — Controlled substances; use of FDA-approved substance upon publication of final rule, etc.

Authorizes the Board of Pharmacy (Board) to designate, deschedule, or reschedule as a controlled substance any substance 30 days after publication in the Federal Register of a final or interim final order or rule designating such substance as a controlled substance or descheduling or rescheduling such substance. Under current law, the Board may act 120 days from such publication date. The bill also provides that a person is immune from prosecution for prescribing, administering, dispensing, or possessing pursuant to a valid prescription a substance approved as a prescription drug by the U.S. Food and Drug Administration on or after July 1, 2017, in accordance with a final or interim final order or rule despite the fact that such substance has not been scheduled by the Board. The immunity provided by the bill remains in effect until the earlier of (i) nine months from the date of the publication of the interim final order or rule or, if published within nine months of the interim final order or rule, the final order or rule or (ii) the substance is scheduled by the Board or by law. This bill is identical to

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Governor: Acts of Assembly Chapter text (CHAP0432) (committee substitute) — source
  2. House: Committee substitute printed 17105340D-H1 (committee substitute) — source
  3. Senate: Bill text as passed Senate and House (SB1403ER) (committee substitute) — source
  4. Senate: Committee substitute printed 17104151D-S1 (committee substitute) — source
  5. Senate: Prefiled and ordered printed; offered 01/11/17 17103740D (committee substitute) — source

Votes

  • Passed House with substitute BLOCK VOTE — 980 (pass) · legislature
  • House substitute agreed to by Senate — 391 (pass) · legislature
  • Reported from Health, Welfare and Institutions with substitute — 210 (pass) · legislature
  • Reported from Education and Health with substitute — 141 (pass) · legislature
  • Read third time and passed Senate — 391 (pass) · legislature
  • Constitutional reading dispensed — 380 (pass) · legislature

Sponsors

  • Siobhan S. Dunnavant — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2017-01-11 Prefiled and ordered printed; offered 01/11/17 17103740D introduction
  • 2017-01-11 Referred to Committee on Education and Health referral-committee
  • 2017-01-16 Assigned Education sub: Health Professions referral-committee
  • 2017-01-23 Read second time reading-2
  • 2017-01-23 Reading of substitute waived
  • 2017-01-23 Committee substitute agreed to 17104151D-S1
  • 2017-01-23 Engrossed by Senate - committee substitute SB1403S1
  • 2017-01-31 Placed on Calendar
  • 2017-01-31 Read first time reading-1
  • 2017-01-31 Referred to Committee on Health, Welfare and Institutions referral-committee
  • 2017-02-10 Read second time reading-2
  • 2017-02-13 Passed by for the day
  • 2017-02-14 Read third time reading-3
  • 2017-02-14 Committee substitute agreed to 17105340D-H1
  • 2017-02-14 Engrossed by House - committee substitute SB1403H1
  • 2017-02-14 Passed House with substitute BLOCK VOTE (98-Y 0-N) passage
  • 2017-02-16 Title replaced 17105340D-H1
  • 2017-02-20 Enrolled
  • 2017-02-20 Signed by Speaker
  • 2017-02-21 Signed by President
  • 2017-02-21 Enrolled Bill communicated to Governor on 2/21/17
  • 2017-02-21 Governor's Action Deadline Midnight, March 27, 2017
  • 2017-03-13 Approved by Governor-Chapter 432 (effective 7/1/17) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/f8b20672-d6b8-472e-ab4b-f3a77bcedecb. Confidence: reported (aggregated from official Virginia legislature records).